Fig. 3From: Advances in studies of tyrosine kinase inhibitors and their acquired resistanceCell signaling pathways induced by Abl kinases. Phosporylated Abl activates oncogenic signaling pathways by activation of ERK5; Rac/Jnk, and STAT 1/3 pathways. These cascades are required for cancer cell growth and transformationBack to article page